Cargando…
Safety and Efficacy of Tocilizumab in the Treatment of Severe Acute Respiratory Syndrome Coronavirus-2 Pneumonia: A Retrospective Cohort Study
Background: Cytokine release storm (CRS) in severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) is thought to be the cause for organ damage and death which is independent of the actual viral burden. Tocilizumab (TCZ), an interleukin-6 receptor antagonist, is approved for the treatment of CR...
Autores principales: | Patel, Atul, Shah, Kinjal, Dharsandiya, Mitkumar, Patel, Ketan, Patel, Tushar, Patel, Mukesh, Reljic, Tea, Kumar, Ambuj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Indian Journal of Medical Microbiology. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706820/ https://www.ncbi.nlm.nih.gov/pubmed/32719218 http://dx.doi.org/10.4103/ijmm.IJMM_20_298 |
Ejemplares similares
-
SARS-CoV-2 Viral Sepsis with Meningoencephalitis
por: Dharsandiya, Mitkumar, et al.
Publicado: (2020) -
Response to the comments received on a case report SARS-CoV-2 viral sepsis with meningoencephalitis
por: Dharsandiya, Mitkumar, et al.
Publicado: (2021) -
P281 Healthy adult with arm swelling and new onset burning pain
por: Shah, Kinjal, et al.
Publicado: (2022) -
P437 Diagnostic utility of serum beta D glucan test to prescribe antifungal treatment and its effect on patient's outcome: a study from a tertiary care center in Western India
por: Patel, Kamlesh, et al.
Publicado: (2022) -
Virological outcome and frequency of low-level viremia in patients receiving generic dolutegravir-containing regimen at a large tertiary care clinic in Western India
por: Patel, Atul K., et al.
Publicado: (2021)